An inhibiting or alleviating agent for amyloid beta (Aβ)-induced damage in hippocampus including an extract from inflamed tissues inoculated with vaccinia virus. And the use of the extract from inflamed tissues inoculated with vaccinia virus in the preparation of an agent for inhibiting or alleviating Aβ-induced damage in hippocampus.